← Eichor
Study identifier: NCT00230685 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia

Condition: Telangiectasia, Hereditary Hemorrhagic  ·  Sponsor: Imperial College London

PhaseN/A
Planned participants2000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

This observational study is for individuals with Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations that are reviewed at the Hammersmith Hospital, London.

This description comes directly from the study's public registry record.

Talk to the study team

Claire L Shovlin  ·  0208 383 1000  ·  c.shovlin@imperial.ac.uk

Always discuss trial participation with your own doctor first.

Locations (1)

Respiratory Medicine, Hammersmith HospitalLondon, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT00230685